These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35962565)

  • 1. Pain measurement in painful skin conditions and rheumatoid arthritis randomized controlled trials: a scoping review to inform pain measurement in hidradenitis suppurativa.
    Hasan SB; Gendra R; James J; Morris D; Orenstein LAV; Ingram JR
    Br J Dermatol; 2022 Dec; 187(6):846-854. PubMed ID: 35962565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of how pain is measured in painful skin conditions and rheumatoid arthritis studies, to determine pain measurement in future hidradenitis suppurativa trials.
    Br J Dermatol; 2022 Dec; 187(6):e196-e221. PubMed ID: 36464931
    [No Abstract]   [Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatments and new assessment instruments for Hidradenitis suppurativa.
    van Straalen KR; Ingram JR; Augustin M; Zouboulis CC
    Exp Dermatol; 2022 Sep; 31 Suppl 1(Suppl 1):33-39. PubMed ID: 35582833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain in Hidradenitis Suppurativa: A Cross-sectional Study of 1,795 Patients.
    Krajewski PK; Matusiak Ł; von Stebut E; Schultheis M; Kirschner U; Nikolakis G; Szepietowski JC
    Acta Derm Venereol; 2021 Jan; 101(1):adv00364. PubMed ID: 33320274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.
    Montero-Vilchez T; Diaz-Calvillo P; Rodriguez-Pozo JA; Cuenca-Barrales C; Martinez-Lopez A; Arias-Santiago S; Molina-Leyva A
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Painful hidradenitis suppurativa.
    Smith HS; Chao JD; Teitelbaum J
    Clin J Pain; 2010 Jun; 26(5):435-44. PubMed ID: 20473053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for hidradenitis suppurativa.
    Ingram JR; Woo PN; Chua SL; Ormerod AD; Desai N; Kai AC; Hood K; Burton T; Kerdel F; Garner SE; Piguet V
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010081. PubMed ID: 26443004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study.
    Vossen ARJV; Schoenmakers A; van Straalen KR; Prens EP; van der Zee HH
    Am J Clin Dermatol; 2017 Oct; 18(5):687-695. PubMed ID: 28429245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics of Pruritus and Pain in Patients with Hidradenitis Suppurativa.
    Matusiak Ł; Szczęch J; Kaaz K; Lelonek E; Szepietowski JC
    Acta Derm Venereol; 2018 Feb; 98(2):191-194. PubMed ID: 28971209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes.
    Thorlacius L; Ingram JR; Garg A; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Christensen R; Jemec GB
    BMJ Open; 2017 Feb; 7(2):e014733. PubMed ID: 28219961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process.
    Ingram JR; Hadjieconomou S; Piguet V
    Br J Dermatol; 2016 Aug; 175(2):263-72. PubMed ID: 26873867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort.
    van Straalen KR; Tzellos T; Alavi A; Benhadou F; Cuenca-Barrales C; Daxhelet M; Daoud M; Efthymiou O; Giamarellos-Bourboulis EJ; Guillem P; Gulliver W; Jemec GBE; Katoulis A; Koenig A; Lazaridou E; Lowes MA; Marzano AV; Matusiak L; Molina-Leyva A; Moltrasio C; Pinter A; Potenza C; Prens EP; Romaní J; Saunte DM; Sayed C; Skroza N; Stergianou D; Szepietowski JC; Trigoni A; Vilarrasa E; Kyrgidis A; Zouboulis CC; van der Zee HH
    Dermatology; 2023; 239(3):362-367. PubMed ID: 36630943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Hidradenitis Suppurativa Evaluation Study (THESEUS): protocol for a prospective cohort study.
    Bates J; Stanton H; Cannings-John R; Thomas KS; Leighton P; Howells LM; Rodrigues J; Howes R; Collier F; Harris C; Gibbons A; Thomas-Jones E; Hood K; Ingram JR
    BMJ Open; 2022 Apr; 12(4):e060815. PubMed ID: 35450918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Color Doppler as a tool for correlating vascularization and pain in hidradenitis suppurativa lesions.
    Nazzaro G; Passoni E; Calzari P; Barbareschi M; Muratori S; Veraldi S; Marzano AV
    Skin Res Technol; 2019 Nov; 25(6):830-834. PubMed ID: 31140660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire.
    Ingram JR; Ciaravino V; Rolleri R; Pansar I; Dias-Barbosa C; Kirby JS
    Dermatology; 2024; 240(1):65-76. PubMed ID: 37820596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceeding report of the Fourth Symposium on Hidradenitis Suppurativa Advances 2019.
    Narla S; Price KN; Sachdeva M; Shah M; Shi V; Hamzavi I; Alavi A; Lowes MA
    J Am Acad Dermatol; 2021 Jan; 84(1):120-129. PubMed ID: 32497690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global consensus process to establish a core dataset for hidradenitis suppurativa registries.
    Wainman HE; Chandran NS; Frew JW; Garg A; Gibbons A; Gierbolini A; Horvath B; Jemec GB; Kirby B; Kirby J; Lowes MA; Martorell A; McGrath BM; Naik HB; Oon HH; Prens E; Sayed CJ; Thorlacius L; Van der Zee HH; Villumsen B; Ingram JR
    Br J Dermatol; 2024 Mar; 190(4):510-518. PubMed ID: 37976235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US.
    Ingram JR; Bettoli V; Espy JI; Kokolakis G; Martorell A; Villani AP; Wallinger H; Coak E; Kasparek T; Muscianisi E; Richardson C; Kimball AB
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1597-1605. PubMed ID: 35445469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.